Tsugumine Shu
Direttore/Membro del Consiglio presso I'ROM GROUP CO., LTD.
Patrimonio netto: 510 685 $ in data 30/04/2024
Profilo
Tsugumine Shu is currently the Director & Head-ISEL Bank Promotions at I'rom Group Co., Ltd.
since 2022 and the Director & Vice President at Id Pharma Co., Ltd.
since 2019.
Previously, he held positions as President at Beijing B&m Biotech Co., Ltd.
and Researcher at DNAVEC Research, Inc. Dr. Shu obtained a doctorate degree from Tokyo University of Agriculture & Technology in 1989.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
I'ROM GROUP CO., LTD.
0.36% | 31/03/2023 | 44 351 ( 0.36% ) | 510 685 $ | 30/04/2024 |
Posizioni attive di Tsugumine Shu
Società | Posizione | Inizio |
---|---|---|
I'ROM GROUP CO., LTD. | Direttore/Membro del Consiglio | 01/07/2016 |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | Direttore/Membro del Consiglio | 01/04/2004 |
Precedenti posizioni note di Tsugumine Shu
Società | Posizione | Fine |
---|---|---|
Beijing B&m Biotech Co., Ltd.
Beijing B&m Biotech Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of JSR Corp., Beijing B & m Biotech Co., Ltd. is a private company that provides medical services and tools. The company is based in Beijing, China. | Presidente | - |
DNAVEC Research, Inc. | Corporate Officer/Principal | - |
Formazione di Tsugumine Shu
Tokyo University of Agriculture & Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
I'rom Group Co., Ltd. | |
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | Health Technology |
Beijing B&m Biotech Co., Ltd.
Beijing B&m Biotech Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of JSR Corp., Beijing B & m Biotech Co., Ltd. is a private company that provides medical services and tools. The company is based in Beijing, China. | Electronic Technology |
DNAVEC Research, Inc. |
- Borsa valori
- Insiders
- Tsugumine Shu